Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30524172)

  • 21. Fertility outcomes following surgery and multiagent chemotherapy in malignant ovarian germ cell tumor survivors: a survey study.
    Bergamini A; Ramaswami R; Froeling F; Papanastasopoulos P; Short D; Aguiar X; Savage PM; Sarwar N; Kaur B; Saso S; Fotopoulou C; Sharma A; Rustin GJS; Seckl M
    Int J Gynecol Cancer; 2023 Nov; 33(11):1750-1756. PubMed ID: 37931975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary.
    Tangir J; Zelterman D; Ma W; Schwartz PE
    Obstet Gynecol; 2003 Feb; 101(2):251-7. PubMed ID: 12576247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncologic and reproductive outcome after fertility-saving surgery in ovarian cancer.
    Ayhan A; Celik H; Taskiran C; Bozdag G; Aksu T
    Eur J Gynaecol Oncol; 2003; 24(3-4):223-32. PubMed ID: 12807228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery.
    Yang ZJ; Liu ZC; Wei RJ; Li L
    Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of outcomes and prognostic factors after fertility-sparing surgery in malignant ovarian germ cell tumors.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2017 Jun; 145(3):513-518. PubMed ID: 28372870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reproductive function after treatment of ovarian germ cell malignancy.
    Anita AN; Rushdan MN
    Med J Malaysia; 2012 Feb; 67(1):71-6. PubMed ID: 22582552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Germ cell tumors of the ovary.
    Pectasides D; Pectasides E; Kassanos D
    Cancer Treat Rev; 2008 Aug; 34(5):427-41. PubMed ID: 18378402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neo-adjuvant chemotherapy in the treatment of advanced malignant germ cell tumors of ovary.
    Talukdar S; Kumar S; Bhatla N; Mathur S; Thulkar S; Kumar L
    Gynecol Oncol; 2014 Jan; 132(1):28-32. PubMed ID: 24145115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor.
    Kang H; Kim TJ; Kim WY; Choi CH; Lee JW; Kim BG; Bae DS
    Gynecol Oncol; 2008 Oct; 111(1):106-10. PubMed ID: 18656249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
    Yang ZJ; Wei RJ; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnancy following conservative surgical treatment of the malignant mixed germ-cell tumor of the ovary--case report.
    Tasic L; Vasiljevic M; Prorocic M; Tasic D; Raznatovic S; Jurisic A
    Eur J Gynaecol Oncol; 2011; 32(6):705-7. PubMed ID: 22335044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Menstrual function and childbearing potential after fertility-sparing surgery and platinum-based chemotherapy for malignant ovarian germ cell tumours.
    Gadducci A; Lanfredini N; Tana R
    Gynecol Endocrinol; 2014 Jul; 30(7):467-71. PubMed ID: 24702194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pregnancy and Delivery After Ovarian Yolk Sac Tumor: A Case Report.
    Alrjoub MM; Sindiani A; Alshriedeh O; Amarin Z
    Am J Case Rep; 2021 Aug; 22():e932091. PubMed ID: 34408122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Childhood ovarian nonseminomatous germ cell tumors: A highly curable disease with few long-term treatment-related toxicities-Results of the French TGM95 study.
    Pavone R; Pacquement H; Pasquet M; Sudour-Bonnange H; Hameury F; Sarnacki S; Chastagner P; Faure-Conter C; Poirée M; Taque S; Patte C; Fresneau B
    Int J Cancer; 2021 Nov; 149(9):1705-1712. PubMed ID: 34146403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fertility sparing surgery for ovarian tumors in children and young adults.
    Abdel-Hady el-S; Abdel-Hady Hemida R; Gamal A; El-Shamey M
    Arch Gynecol Obstet; 2012 Feb; 285(2):469-71. PubMed ID: 21701836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Giving Birth After Fertility Sparing Treatment for a Yolk Sac Tumour: Case Report.
    Makris GM; Fotiou A; Chrelias G; Battista MJ; Chrelias C
    J Clin Diagn Res; 2017 Aug; 11(8):QD12-QD13. PubMed ID: 28969219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.
    Chen RF; Li J; Zhu TT; Yu HL; Lu X
    J Ovarian Res; 2016 Mar; 9():16. PubMed ID: 26988551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival and reproductive function after treatment of malignant germ cell ovarian tumors.
    Zanetta G; Bonazzi C; Cantù M; Binidagger S; Locatelli A; Bratina G; Mangioni C
    J Clin Oncol; 2001 Feb; 19(4):1015-20. PubMed ID: 11181664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reproductive outcomes following fertility-sparing surgery for malignant ovarian germ cell tumors: A systematic review of the literature.
    Morrison A; Nasioudis D
    Gynecol Oncol; 2020 Aug; 158(2):476-483. PubMed ID: 32513565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor.
    de La Motte Rouge T; Pautier P; Duvillard P; Rey A; Morice P; Haie-Meder C; Kerbrat P; Culine S; Troalen F; Lhommé C
    Ann Oncol; 2008 Aug; 19(8):1435-1441. PubMed ID: 18408223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.